D-1194-2022 Class II Ongoing
FDA drug recall D-1194-2022 was initiated by TMC Acquisition LLC dba Tailor Made Compounding on March 7, 2022 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 39.
Recall Details
- Product Type
- Drugs
- Report Date
- July 20, 2022
- Initiation Date
- March 7, 2022
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 39
Product Description
Anastrozole/Testosterone Cypionate/Propionate 1mg/160mg/40mg/mL, 10 mL-vial, Room Temperature, Tailor Made Compounding
Reason for Recall
Lack of Assurance of Sterility
Distribution Pattern
Nationwide USA and Puerto Rico
Code Information
Batch #: 10182113A1, Exp 4/16/2022.